Dual-Chip Sequencing: How the GP1000 Compresses the Cost of Genomics at Scale

GP1000 High-Throughput NGS Sequencing System | Dual-Chip DNA Sequencer

The GP1000, a dual-chip next-generation sequencing system, is engineered to address a persistent bottleneck in high-throughput genomics: the trade-off between data volume and operational flexibility. By allowing two independent sequencing runs on separate chips simultaneously, it enables laboratories to mix project types, stagger start times, or dedicate one chip to validation while the other handles production.

With a maximum output of 2 Tb per run and a Q40 score exceeding 85%, the system sits comfortably in the high-accuracy tier required for clinical applications, including oncology panel sequencing and rare disease diagnostics. Its support for both DNA and RNA workflows reduces the need for separate instruments, simplifying lab management and reagent supply chains.

For research institutions and biotech firms scaling their genomic operations, the dual-chip architecture offers a practical path to higher sample throughput without renegotiating laboratory workflows or investing in additional automation. It aligns with a broader trend toward modular, resource-efficient lab infrastructure in China’s rapidly growing sequencing service sector.

The GP1000 reflects a maturing domestic supply chain capable of producing instruments that compete on cost and uptime. For procurement decisions, it shifts the calculus from raw read count toward total run economics and operational redundancy.

Why it matters:
For labs processing large batches or multiple project streams, the parallel chip architecture reduces idle time and per-sample cost. It also points to a growing domestic capability in precision instrumentation—an area where China is increasingly self-reliant.

View Product →